I/O Summit Europe 2024
Hilton London Canary Wharf S Quay Square, Marsh Wall, London, United KingdomJoin Discovery Life Sciences at I/O Summit Europe 2024 April 23-25, 2024 | Hilton London Canary Wharf, London, England
IND-enabling ADME studies to predict drug-drug interaction.
Testing for mRNA and enzyme activity for a comprehensive portfolio of inducible enzymes, including CYP1A2, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP3A4, UGTs and transporters
In vitro inhibition testing for a range of drug metabolizing enzymes, including CYPs (reversible and TDI), UGTs, Oxidases (e.g., AO, MAO), and Esterases (e.g., CES, ChE)
Comprehensive Phase I/II (CYP, UGT, AO/XO, FMO, CES, SULT) enzyme identification using Gentest Supersomes®, human liver fractions and human hepatocytes, including enzyme kinetics (Km, CLint) and fm determination (selective chemical inhibition, RAF/ISEF scaling)
Customized ADME analyses for unusual drug metabolizing enzymes, custom expressions, extrahepatic tissues, and assay transfers.
Join Discovery Life Sciences at I/O Summit Europe 2024 April 23-25, 2024 | Hilton London Canary Wharf, London, England
Join Discovery Life Sciences in Booth #11 at CB & CDx London 2024 April 24-25, 2024 | Millennium Gloucester Hotel London Kensington, London, England
Join Discovery Life Sciences at Cyto Conference 2024 May 4-8, 2024 | Edinburgh International Convention Center, Edinburgh, Scotland
Copyright © 2024 Discovery Life Sciences. All rights reserved.
Designed & Developed by Altitude Marketing